These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis. Southern KW; Patel S; Sinha IP; Nevitt SJ Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364 [TBL] [Abstract][Full Text] [Related]
8. Understanding how cystic fibrosis mutations cause a loss of Cl- channel function. Sheppard DN; Ostedgaard LS Mol Med Today; 1996 Jul; 2(7):290-7. PubMed ID: 8796909 [TBL] [Abstract][Full Text] [Related]
9. A new era of personalized medicine for cystic fibrosis - at last! Quon BS; Wilcox PG Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544 [TBL] [Abstract][Full Text] [Related]
11. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient. Egan ME Clin Chest Med; 2022 Dec; 43(4):717-725. PubMed ID: 36344076 [TBL] [Abstract][Full Text] [Related]
12. New Therapies to Correct the Cystic Fibrosis Basic Defect. Bergeron C; Cantin AM Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201249 [TBL] [Abstract][Full Text] [Related]
13. Human Molecular Genetics and the long road to treating cystic fibrosis. Harris A Hum Mol Genet; 2021 Oct; 30(R2):R264-R273. PubMed ID: 34245257 [TBL] [Abstract][Full Text] [Related]
14. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses. Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809 [TBL] [Abstract][Full Text] [Related]
15. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations. Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449 [TBL] [Abstract][Full Text] [Related]
17. Advances in gene therapy for cystic fibrosis lung disease. Yan Z; McCray PB; Engelhardt JF Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy for cystic fibrosis: new tools for precision medicine. Lee JA; Cho A; Huang EN; Xu Y; Quach H; Hu J; Wong AP J Transl Med; 2021 Oct; 19(1):452. PubMed ID: 34717671 [TBL] [Abstract][Full Text] [Related]
19. Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF. Egan ME Pediatr Pulmonol; 2021 Feb; 56 Suppl 1(Suppl 1):S32-S39. PubMed ID: 32681713 [TBL] [Abstract][Full Text] [Related]
20. Towards the pharmacogenomics of cystic fibrosis. Sangiuolo F; D'Apice MR; Bruscia E; Lucidi V; Novelli G Pharmacogenomics; 2002 Jan; 3(1):75-87. PubMed ID: 11966405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]